RAGE (receptor for advanced glycation end-products) is expressed on multiple cell types implicated in the progression of atherosclerosis and plays a role in DAA (diabetes-associated atherosclerosis). The aim of the present study was to determine the relative role of either BM (bone marrow)- or non-BM-derived RAGE in the pathogenesis of STZ (streptozotocin)-induced DAA. Male ApoE (apolipoprotein E)-null (ApoE−/−:RAGE+/+) and ApoE:RAGE-null (ApoE−/−:RAGE−/−) mice at 7 weeks of age were rendered diabetic with STZ. At 8 weeks of age, ApoE−/− and ApoE−/−:RAGE−/− control and diabetic mice received BM from either RAGE-null or RAGE-bearing mice, generating various chimaeras. After 10 and 20 weeks of diabetes, mice were killed and gene expression and atherosclerotic lesion formation were evaluated respectively. Deletion of RAGE in either the BM cells or non-BM cells both resulted in a significant attenuation in DAA, which was associated with reduced VCAM-1 (vascular cell adhesion molecule-1) expression and translated into reduced adhesion in vitro. In conclusion, the results of the present study highlight the importance of both BM- and non-BM-derived RAGE in attenuating the development of DAA.
Skip Nav Destination
Article navigation
Research Article|
June 17 2014
Role of bone-marrow- and non-bone-marrow-derived receptor for advanced glycation end-products (RAGE) in a mouse model of diabetes-associated atherosclerosis
Christine Koulis;
*Diabetic Complications Group, Baker IDI Heart and Diabetes Research Institute, Melbourne, VIC 8008, Australia
Correspondence: Dr Christine Koulis (email [email protected]).
Search for other works by this author on:
Peter Kanellakis;
Peter Kanellakis
*Diabetic Complications Group, Baker IDI Heart and Diabetes Research Institute, Melbourne, VIC 8008, Australia
Search for other works by this author on:
Raelene J. Pickering;
Raelene J. Pickering
*Diabetic Complications Group, Baker IDI Heart and Diabetes Research Institute, Melbourne, VIC 8008, Australia
Search for other works by this author on:
Despina Tsorotes;
Despina Tsorotes
*Diabetic Complications Group, Baker IDI Heart and Diabetes Research Institute, Melbourne, VIC 8008, Australia
Search for other works by this author on:
Andrew J. Murphy;
Andrew J. Murphy
*Diabetic Complications Group, Baker IDI Heart and Diabetes Research Institute, Melbourne, VIC 8008, Australia
Search for other works by this author on:
Stephen P. Gray;
Stephen P. Gray
*Diabetic Complications Group, Baker IDI Heart and Diabetes Research Institute, Melbourne, VIC 8008, Australia
Search for other works by this author on:
Merlin C. Thomas;
Merlin C. Thomas
*Diabetic Complications Group, Baker IDI Heart and Diabetes Research Institute, Melbourne, VIC 8008, Australia
Search for other works by this author on:
Karin A. M. Jandeleit-Dahm;
Karin A. M. Jandeleit-Dahm
*Diabetic Complications Group, Baker IDI Heart and Diabetes Research Institute, Melbourne, VIC 8008, Australia
Search for other works by this author on:
Mark E. Cooper;
Mark E. Cooper
*Diabetic Complications Group, Baker IDI Heart and Diabetes Research Institute, Melbourne, VIC 8008, Australia
Search for other works by this author on:
Terri J. Allen
Terri J. Allen
*Diabetic Complications Group, Baker IDI Heart and Diabetes Research Institute, Melbourne, VIC 8008, Australia
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
January 22 2014
Revision Received:
March 25 2014
Accepted:
April 11 2014
Accepted Manuscript online:
April 11 2014
Online ISSN: 1470-8736
Print ISSN: 0143-5221
© The Authors Journal compilation © 2014 Biochemical Society
2014
Clin Sci (Lond) (2014) 127 (7): 485–497.
Article history
Received:
January 22 2014
Revision Received:
March 25 2014
Accepted:
April 11 2014
Accepted Manuscript online:
April 11 2014
Citation
Christine Koulis, Peter Kanellakis, Raelene J. Pickering, Despina Tsorotes, Andrew J. Murphy, Stephen P. Gray, Merlin C. Thomas, Karin A. M. Jandeleit-Dahm, Mark E. Cooper, Terri J. Allen; Role of bone-marrow- and non-bone-marrow-derived receptor for advanced glycation end-products (RAGE) in a mouse model of diabetes-associated atherosclerosis. Clin Sci (Lond) 1 October 2014; 127 (7): 485–497. doi: https://doi.org/10.1042/CS20140045
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() |